{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-116985","form_type":"8-K","ticker":"KTTA","cik":"0001841330","company_name":"Pasithea Therapeutics Corp.","filed_at":"2025-12-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.756613+00:00","generated_at":"2026-05-16T15:46:23.799357+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Pasithea raises ~$60M in public offering of common stock and pre-funded warrants","bullets":["Gross proceeds of $60.0M; net proceeds of ~$54.9M after fees and expenses.","Offering priced at $0.75 per share/warrant; 80M shares (or pre-funded warrants) sold.","Led by healthcare investors including Vivo Capital, Janus Henderson, Coastlands Capital.","Insiders (CEO, CFO, board members) bought 400k shares at same price.","Cash runway extended through at least first half 2028."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-116985","json":"https://secwatch.observer/filing/0001213900-25-116985.json","markdown":"https://secwatch.observer/filing/0001213900-25-116985.md","text":"https://secwatch.observer/filing/0001213900-25-116985.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1841330/000121390025116985/0001213900-25-116985-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1841330/000121390025116985/ea0267824-8k_pasithea.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T15:46:23.799357+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a8345933b6483829d2bfaa9ac0509e09ced0f90d","claim":"Pasithea Therapeutics Corp. issued 4,000,000 shares of Common Stock of warrant to H.C. Wainwright & Co., LLC or its designees.","evidence_excerpt":"the Company issued to Wainwright or its designees, warrants (the “ Placement Agent Warrants ”) to purchase up to an aggregate of 4,000,000 shares of Common Stock (the “ Placement Agent Warrant Shares ”) at an exercise price equal to $0.9375 per share","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1841330/000121390025116985/0001213900-25-116985-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"4,000,000 shares of Common Stock"},{"label":"Purchaser","value":"H.C. Wainwright & Co., LLC or its designees"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}